Jouroukhin Y - Search Results

1

3R tau expression modifies behavior in transgenic mice.

Shiryaev N, Jouroukhin Y, Gozes I. Shiryaev N, et al. Among authors: jouroukhin y. J Neurosci Res. 2010 Sep;88(12):2727-35. doi: 10.1002/jnr.22431. J Neurosci Res. 2010. PMID: 20544828

2

NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.

Shiryaev N, Jouroukhin Y, Giladi E, Polyzoidou E, Grigoriadis NC, Rosenmann H, Gozes I. Shiryaev N, et al. Among authors: jouroukhin y. Neurobiol Dis. 2009 May;34(2):381-8. doi: 10.1016/j.nbd.2009.02.011. Epub 2009 Mar 2. Neurobiol Dis. 2009. PMID: 19264130

3

D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.

Jouroukhin Y, Ostritsky R, Gozes I. Jouroukhin Y, et al. J Mol Neurosci. 2012 Nov;48(3):597-602. doi: 10.1007/s12031-012-9882-6. J Mol Neurosci. 2012. PMID: 22956189 Review.

4

NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.

Jouroukhin Y, Ostritsky R, Assaf Y, Pelled G, Giladi E, Gozes I. Jouroukhin Y, et al. Neurobiol Dis. 2013 Aug;56:79-94. doi: 10.1016/j.nbd.2013.04.012. Epub 2013 Apr 28. Neurobiol Dis. 2013. PMID: 23631872

5

Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.

Amram N, Hacohen-Kleiman G, Sragovich S, Malishkevich A, Katz J, Touloumi O, Lagoudaki R, Grigoriadis NC, Giladi E, Yeheskel A, Pasmanik-Chor M, Jouroukhin Y, Gozes I. Amram N, et al. Among authors: jouroukhin y. Mol Psychiatry. 2016 Oct;21(10):1467-76. doi: 10.1038/mp.2015.208. Epub 2016 Jan 19. Mol Psychiatry. 2016. PMID: 26782054

6

A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease.

Matsuoka Y, Jouroukhin Y, Gray AJ, Ma L, Hirata-Fukae C, Li HF, Feng L, Lecanu L, Walker BR, Planel E, Arancio O, Gozes I, Aisen PS. Matsuoka Y, et al. Among authors: jouroukhin y. J Pharmacol Exp Ther. 2008 Apr;325(1):146-53. doi: 10.1124/jpet.107.130526. Epub 2008 Jan 16. J Pharmacol Exp Ther. 2008. PMID: 18199809

7

DISC1 signaling in cocaine addiction: Towards molecular mechanisms of co-morbidity.

Gancarz A, Jouroukhin Y, Saito A, Shevelkin A, Mueller LE, Kamiya A, Dietz DM, Pletnikov MV. Gancarz A, et al. Among authors: jouroukhin y. Neurosci Res. 2016 Apr;105:70-4. doi: 10.1016/j.neures.2015.09.001. Epub 2015 Sep 15. Neurosci Res. 2016. PMID: 26385055 Free PMC article.

8

Homeostatic regulation of neuronal excitability by probiotics in male germ-free mice.

Kim J, Kim DW, Lee A, Mason M, Jouroukhin Y, Woo H, Yolken RH, Pletnikov MV. Kim J, et al. Among authors: jouroukhin y. J Neurosci Res. 2022 Feb;100(2):444-460. doi: 10.1002/jnr.24999. Epub 2021 Dec 21. J Neurosci Res. 2022. PMID: 34935171

9

Expression of mutant DISC1 in Purkinje cells increases their spontaneous activity and impairs cognitive and social behaviors in mice.

Shevelkin AV, Terrillion CE, Abazyan BN, Kajstura TJ, Jouroukhin YA, Rudow GL, Troncoso JC, Linden DJ, Pletnikov MV. Shevelkin AV, et al. Neurobiol Dis. 2017 Jul;103:144-153. doi: 10.1016/j.nbd.2017.04.008. Epub 2017 Apr 6. Neurobiol Dis. 2017. PMID: 28392471 Free PMC article.

10

Molecular neuroimaging of post-injury plasticity.

Jouroukhin Y, Nonyane BA, Gilad AA, Pelled G. Jouroukhin Y, et al. J Mol Neurosci. 2014 Dec;54(4):630-8. doi: 10.1007/s12031-014-0347-y. Epub 2014 Jun 10. J Mol Neurosci. 2014. PMID: 24909382 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page